BrainsWay, a medical technology company, saw its stock surge on Monday after securing a $20 million investment from Valor Equity Partners. The investment will fuel BrainsWay’s expansion, including increasing market awareness, enhancing data analysis, and expanding access to its Deep TMS technology. The deal also gives Valor potential board representation based on its ownership stake.